Skip to main content

Viking Therapeutics Inc. Common Stock (VKTX)

About The Company

VKTX Stock Market Logo

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company’s clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

IPO Year Sector Industry
2015 Health Care Biotechnology: Pharmaceutical Preparations

Viking Therapeutics Inc. (VKTX) Latest News

Company Contact & Address (VKTX)

Corporate Headquarters Phone Website
United States
+1 858 704-4660 Official VKTX Website

VKTX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ VKTX

Jobs & Employment at Viking Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Employment, Jobs & Careers at Viking Therapeutics Inc. (VKTX)

Related & Similar Stock Symbols

PYCR Stock Market Price & News


Paycor HCM Inc. Common Stock

WHD Stock Market Price & News


Cactus Inc. Class A Common Stock

PGNY Stock Market Price & News


Progyny Inc. Common Stock